Colonoscopy

2024: Russia developed and began to use RiGinaM technology to assess the state of the intestines without colonoscopy

A new RiGinaM technology has been developed and began to be used in Russia, which allows diagnosing the intestinal condition without using colonoscopy. This became known at the end of August 2024. The innovative technique is already being used in experimental mode in the laboratory of Sechenov University in cooperation with the German clinic "Charite" and is aimed at diagnosing inflammatory diseases. Read more here.

2023

Russia has created a system for detecting colon neoplasms that are not visible to a human doctor

On November 24, 2023, Russian scientists reported National Medical Research Center (NMSC) of Coloproctology named after A.N. Ryzhikh Ministry of Health Russia on the development of a new system for detecting malignant colon formations that are not visible to a human doctor. The solution called ArtInCol is based on funds. artificial intelligence More. here

A swallowed diagnostic capsule is presented that replaces colonoscopy

On September 8, 2023, a team of US researchers from MIT and Boston University announced the development of a smart pill designed to diagnose bowel disease.

Experts say current invasive methods to assess bowel conditions, such as colonoscopy and other endoscopic procedures, make patients uncomfortable. In addition, they do not allow the detection of molecular biomarkers of diseases in real time. The new ingestible capsule solves these problems.

Capsule Development Team

The smart tablet, which is comparable in size to blueberry berry, contains specially created live bacteria, electronics and a tiny battery. When bacteria capture a specific molecule, they emit light. The capsule's electronics then convert this light into a signal that can wirelessly be transmitted through the patient's body to a smartphone or computer in real time - as the pill passes through the intestines.

The capsule may signal the presence of nitric oxide and hydrogen sulfide byproducts, which are important markers of inflammation associated with bowel disease. The pill can be tuned to detect other biomarkers as well. Researchers believe the technology has the potential to be a "game changer in the diagnosis and treatment of bowel disease." In addition, according to the authors of the project, the proposed combination of bacteria and electronics will help in the creation of new generation devices for health monitoring.

Thanks to this development, we are creating a unique platform for assessing the state of the gastrointestinal tract, which we expect will be able to help many patients, says Giovanni Traverso, one of the lead authors of the study.[1]

Notes